Seeking Alpha


Send Message
View as an RSS Feed
View robtcheng's Comments BY TICKER:

Latest  |  Highest rated
  • Dendreon: Profits Ahead as Provenge Gets Reimbursement Approval From Medicare [View article]
    Yours is a reasonable assessment of Dendreon's current status and severely damaged potential to become a big biotech company. However, you forgot (or you were too polite) to mention that Dendreon's Chairman Dr. Mitch Gold was responsible for mismanagement of the Company. He has no more credibility with shareholders. He is now an liability to Dendreon. He must be removed for the Company to have any hope of a future.

    Even though I believe institutional investors like SAC and Soros will force the removal of Mitch Gold. To protect our own investment as individual investors, I think we should be united to call for the removal of Dr. Gold from the CEO position.
    Aug 16, 2011. 12:21 PM | 1 Like Like |Link to Comment
  • Dendreon Is Not In Trouble! [View instapost]
    Information on Motley Fool has no value. I know that for many years. Saul, thanks for putting them in the right place.
    Aug 10, 2010. 01:47 PM | 2 Likes Like |Link to Comment
  • Dendreon Learns From ICOS' Mistake [View article]
    Saul, you are the best biotech writer on Seeking Alpha. Great article on partnering or not partnering.
    Jul 8, 2010. 09:28 PM | 4 Likes Like |Link to Comment
  • Dendreon, The Fabled "Next Amgen"  [View instapost]
    This article is indeed the most comprehensive analysis of a biotech stock I ever read on Seeking Alpha. SaulK deserves to be congratulated for his knowledgeable, in-depth analysis of Dendreon. Please make him a Contributor so that we can read more of his writings.
    Jul 8, 2010. 08:21 PM | 12 Likes Like |Link to Comment